Abstract: The present disclosure relates to wireless sensor networks installation, deployment, maintenance, and operation. A distributed network of wireless tags enable a wide variety of different indoor and outdoor applications to be implemented, including asset finding, workflow automation, and internet-of-things applications. The physical premises environment may be any location in which there are persons, places or things to be monitored, tracked, sensed, or inventoried, or other defined space. The distributed network of wireless tags is associated with a wireless client device that enables a customer to configure and retrieve status data, event data, and sensor data from wireless tags and other components in the physical premises environment. Embodiments utilize different types of network nodes to collect data from the physical premises environment. Examples of the types of data that may be collected by the wireless tags include asset status information, event data, and sensor data.

Abstract: The present disclosure relates to wireless sensor networks installation, deployment, maintenance, and operation. A distributed network of wireless tags enable a wide variety of different indoor and outdoor applications to be implemented, including asset finding, workflow automation, and internet-of-things applications. The physical premises environment may be any location in which there are persons, places or things to be monitored, tracked, sensed, or inventoried, or other defined space. The distributed network of wireless tags is associated with a wireless client device that enables a customer to configure and retrieve status data, event data, and sensor data from wireless tags and other components in the physical premises environment. Embodiments utilize different types of network nodes to collect data from the physical premises environment. Examples of the types of data that may be collected by the wireless tags include asset status information, event data, and sensor data.

Abstract: The present disclosure relates to wireless sensor networks installation, deployment, maintenance, and operation. A distributed network of wireless tags enable a wide variety of different indoor and outdoor applications to be implemented, including asset finding, workflow automation, and internet-of-things applications. The physical premises environment may be any location in which there are persons, places or things to be monitored, tracked, sensed, or inventoried, or other defined space. The distributed network of wireless tags is associated with a wireless client device that enables a customer to configure and retrieve status data, event data, and sensor data from wireless tags and other components in the physical premises environment. Embodiments utilize different types of network nodes to collect data from the physical premises environment. Examples of the types of data that may be collected by the wireless tags include asset status information, event data, and sensor data.

Abstract: The present disclosure relates to wireless sensor networks installation, deployment, maintenance, and operation. A distributed network of wireless tags enable a wide variety of different indoor and outdoor applications to be implemented, including asset finding, workflow automation, and internet-of-things applications. The physical premises environment may be any location in which there are persons, places or things to be monitored, tracked, sensed, or inventoried, or other defined space. The distributed network of wireless tags is associated with a wireless client device that enables a customer to configure and retrieve status data, event data, and sensor data from wireless tags and other components in the physical premises environment. Embodiments utilize different types of network nodes to collect data from the physical premises environment. Examples of the types of data that may be collected by the wireless tags include asset status information, event data, and sensor data.

Abstract: The present disclosure relates to wireless sensor networks installation, deployment, maintenance, and operation. A distributed network of wireless tags enable a wide variety of different indoor and outdoor applications to be implemented, including asset finding, workflow automation, and internet-of-things applications. The physical premises environment may be any location in which there are persons, places or things to be monitored, tracked, sensed, or inventoried, or other defined space. The distributed network of wireless tags is associated with a wireless client device that enables a customer to configure and retrieve status data, event data, and sensor data from wireless tags and other components in the physical premises environment. Embodiments utilize different types of network nodes to collect data from the physical premises environment. Examples of the types of data that may be collected by the wireless tags include asset status information, event data, and sensor data.

Abstract: The invention provided Mucorales CotH antibodies, polypeptides, encoding nucleic acid molecules, and uses thereof. The Mucorales CotH antibodies, polypeptides and encoding nucleic acids disclosed herein can be advantageously used to diagnose, treat or prevent fungal conditions, in particular mucormycosis.

Abstract: Embodiments disclosed herein relate to compositions comprising extracellular thaumatin domain proteins, or portions thereof (e.g., CalA polypeptides, or portions thereof), and compositions comprising binding agents (e.g., antibodies, fragments thereof, and the like) that bind specifically to CalA polypeptides, and methods of using the same for preventing or treating a fungal infection.

Abstract: The invention provided Mucorales CotH antibodies, polypeptides, encoding nucleic acid molecules, and uses thereof. The Mucorales CotH antibodies, polypeptides and encoding nucleic acids disclosed herein can be advantageously used to diagnose, treat or prevent fungal conditions, in particular mucormycosis.

Abstract: The present invention provides therapeutic compositions and methods for treating and preventing fungal disease or conditions including mucormycosis. The therapeutic methods and compositions of the invention include antibody, antibody fragments, siRNA and vaccine compositions having or directed against a GRP78 polypeptide or an antigenic fragment of the polypeptide.

Abstract: The invention provided Mucorales CotH polypeptides and encoding nucleic acid molecules. The Mucorales CotH polypeptides and encoding nucleic acids can be advantageously used to diagnose, treat or prevent fungal conditions, in particular mucormycosis.

Abstract: The present invention provides therapeutic compositions and methods for treating and preventing fungal disease or conditions including mucormycosis. The therapeutic methods and compositions of the invention include antibody, antibody fragment, siRNA and vaccine compositions having or directed against a GRP78 polypeptide or an antigenic fragment of the polypeptide.

Abstract: A system for use in automated test equipment. In one embodiment, the system includes a configurable integrated circuit (IC) programmable to provide test patterns for use in automated test equipment. The configurable IC includes a configurable interface core that is programmable to provide functionality of one or more protocol based interfaces for a device under test (DUT) and is programmable to interface with the DUT. The system also includes a connection configurable to couple the configurable IC to the DUT.

Abstract: The present invention provides therapeutic compositions and methods for treating and preventing fungal disease or conditions including mucormycosis. The therapeutic methods and compositions of the invention include antibody, antibody fragment, siRNA and vaccine compositions having or directed against a GRP78 polypeptide or an antigenic fragment of the polypeptide.

Abstract: The invention provided Mucorales CotH polypeptides and encoding nucleic acid molecules. The Mucorales CotH polypeptides and encoding nucleic acids can be advantageously used to diagnose, treat or prevent fungal conditions, in particular mucormycosis.

Abstract: A system for use in automated test equipment. In one embodiment, the system includes a configurable integrated circuit (IC) programmable to provide test patterns for use in automated test equipment. The configurable IC includes a configurable interface core that is programmable to provide functionality of one or more protocol based interfaces for a device under test (DUT) and is programmable to interface with the DUT. The system also includes a connection configurable to couple the configurable IC to the DUT.

Abstract: The present invention provides therapeutic compositions and methods for treating and preventing fungal disease or conditions including mucormycosis. The therapeutic methods and compositions of the invention include antibody, antibody fragment, siRNA and vaccine compositions having or directed against a GRP78 polypeptide or an antigenic fragment of the polypeptide.

Abstract: The invention provides a vaccine including an isolated Als protein family member having cell adhesion activity, or an immunogenic fragment thereof, with an adjuvant in a pharmaceutically acceptable medium. The invention also provides a method of treating or preventing hematogenously disseminated or mucocutaneous candidiasis. The method includes administering an immunogenic amount of a vaccine an isolated Als protein family member having cell adhesion activity, or an immunogenic fragment thereof, in a pharmaceutically acceptable medium.

Abstract: The invention provides a vaccine including an isolated Als protein family member having cell adhesion activity, or an immunogenic fragment thereof, with an adjuvant in a pharmaceutically acceptable medium. The invention also provides a method of treating or preventing hematogenously disseminated or mucocutaneous candidiasis. The method includes administering an immunogenic amount of a vaccine an isolated Als protein family member having cell adhesion activity, or an immunogenic fragment thereof, in a pharmaceutically acceptable medium. A method of treating or preventing disseminated candidiasis also is provided that includes administering an effective amount of an isolated Als protein family member having cell adhesion activity, or an functional fragment thereof, to inhibit the binding or invasion of Candida to a host cell or tissue.

Abstract: The invention provides a vaccine including an isolated Als protein family member having cell adhesion activity, or an immunogenic fragment thereof, with an adjuvant in a pharmaceutically acceptable medium. The invention also provides a method of treating or preventing disseminated candidiasis. The method includes administering an immunogenic amount of a vaccine an isolated Als protein family member having cell adhesion activity, or an immunogenic fragment thereof, in a pharmaceutically acceptable medium. A method of treating or preventing disseminated candidiasis also is provided that includes administering an effective amount of an isolated Als protein family member having cell adhesion activity, or an functional fragment thereof, to inhibit the binding or invasion of Candida to a host cell or tissue.